Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension.
Halbach M, Grothaus D, Hoffmann F, Madershahian N, Kuhr K, Reuter H. Halbach M, et al. Among authors: hoffmann f, madershahian n, reuter h, kuhr k, grothaus d. Clin Auton Res. 2020 Dec;30(6):541-548. doi: 10.1007/s10286-020-00670-9. Epub 2020 Feb 12. Clin Auton Res. 2020. PMID: 32052254 Free PMC article.
PURPOSE: Baroreflex activation therapy (BAT) has been shown to lower blood pressure in patients with resistant hypertension. ...Heart rate was 75 16 bpm before BAT and 72 12 bpm at latest follow-up (p = 0.35). CONCLUSIONS: Rate and dur
PURPOSE: Baroreflex activation therapy (BAT) has been shown to lower blood pressure in patients with resistan
Correction to: Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension.
Halbach M, Grothaus D, Hoffmann F, Madershahian N, Kuhr K, Reuter H. Halbach M, et al. Among authors: hoffmann f, madershahian n, reuter h, kuhr k, grothaus d. Clin Auton Res. 2021 Jul 23. doi: 10.1007/s10286-021-00819-0. Online ahead of print. Clin Auton Res. 2021. PMID: 34297249 No abstract available.